Alternatively spliced isoforms of WT1 control podocyte-specific gene expression.

Area of Science:

• Nephrology
• Molecular Biology
• Genetics

Background:

• The Wilms' tumor suppressor WT1 is critical for podocyte function and is implicated in Denys-Drash and Frasier syndromes.
• WT1 mutations disrupt kidney development, highlighting its importance in podocyte biology.

Purpose of the Study:

• To investigate the general and isoform-specific functions of WT1 in podocyte differentiation using an integrative approach.
• To identify direct WT1 targets and understand the role of WT1 isoforms in regulating podocyte-specific genes.

Main Methods:

• Chromatin immunoprecipitation sequencing (ChIP-Seq) to identify WT1 binding sites.
• Exon array and genetic analyses in mice to study WT1 function and its isoforms.
• Bioinformatic analysis to identify coactivator binding sites and gene regulatory networks.

Main Results:

• WT1 directly regulates nearly half of podocyte-specific genes.
• The WT1 (+KTS) isoform specifically controls a subset of genes, including MAGI2.
• MAGI2α is essential for nephrin localization and slit diaphragm complex assembly.
• MAGI2 is reduced in glomerular injury models and human kidney diseases.

Conclusions:

• WT1 plays a central role in podocyte differentiation.
• The MAGI2α isoform is critical for slit diaphragm assembly.
• MAGI2 may play a causative role in the etiology of glomerular disorders.